In the univariate analysis, tumor location, metastasis stage, ECOG status, tumor length, pre-treatment serum levels of albumin and alanine transaminase, level of hemoglobin, and therapeutic response (including complete and partial responses) to CCRT were associated significantly with the overall survival (Table 2). This evidence concerns the gene GPT and neoplasm.